Debra Benator

3.1k total citations
59 papers, 2.1k citations indexed

About

Debra Benator is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Debra Benator has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 36 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Debra Benator's work include Tuberculosis Research and Epidemiology (19 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers) and HIV/AIDS drug development and treatment (16 papers). Debra Benator is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers) and HIV/AIDS drug development and treatment (16 papers). Debra Benator collaborates with scholars based in United States, South Africa and Peru. Debra Benator's co-authors include William J. Burman, Awal Khan, Marc Weiner, Fred M. Gordin, Andrew Vernon, Lorna Bozeman, Andrew Vernon, Stephen E. Weis, Charles A. Peloquin and Brenda Jones and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Debra Benator

53 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra Benator United States 21 1.5k 1.3k 649 143 134 59 2.1k
Chandrasekaran Padmapriyadarsini India 23 1.2k 0.8× 786 0.6× 353 0.5× 64 0.4× 58 0.4× 110 1.6k
Peter Phillips Canada 30 1.4k 0.9× 1.5k 1.1× 295 0.5× 92 0.6× 87 0.6× 76 2.3k
Lee B. Reichman United States 28 1.5k 1.0× 1.5k 1.1× 573 0.9× 69 0.5× 82 0.6× 98 2.3k
Alice K. Pau United States 20 1.5k 1.0× 1.4k 1.1× 317 0.5× 109 0.8× 108 0.8× 60 2.7k
Işık Somuncu Johansen Denmark 23 1.4k 0.9× 1.1k 0.8× 613 0.9× 50 0.3× 33 0.2× 176 2.1k
Weerawat Manosuthi Thailand 29 1.9k 1.3× 1.4k 1.1× 402 0.6× 196 1.4× 60 0.4× 118 2.5k
Gregory P. Bisson United States 23 1.4k 0.9× 1000 0.8× 317 0.5× 61 0.4× 43 0.3× 70 1.9k
George PrayGod Tanzania 20 853 0.6× 549 0.4× 305 0.5× 45 0.3× 107 0.8× 74 1.4k
Anne F. Luetkemeyer United States 20 851 0.6× 863 0.7× 174 0.3× 37 0.3× 222 1.7× 58 1.5k
Sasisopin Kiertiburanakul Thailand 26 2.0k 1.3× 1.2k 0.9× 279 0.4× 171 1.2× 74 0.6× 156 2.7k

Countries citing papers authored by Debra Benator

Since Specialization
Citations

This map shows the geographic impact of Debra Benator's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Benator with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Benator more than expected).

Fields of papers citing papers by Debra Benator

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Benator. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Benator. The network helps show where Debra Benator may publish in the future.

Co-authorship network of co-authors of Debra Benator

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Benator. A scholar is included among the top collaborators of Debra Benator based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Benator. Debra Benator is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Phillips, Patrick, Charles A. Peloquin, Andreas H. Diacon, et al.. (2025). Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(7). 1277–1287. 1 indexed citations
3.
4.
Lyon, Maureen E., Rachel K. Scott, Debra Benator, et al.. (2020). Effect of FAmily CEntered (FACE®) Advance Care Planning on Longitudinal Congruence in End-of-Life Treatment Preferences: A Randomized Clinical Trial. AIDS and Behavior. 24(12). 3359–3375. 15 indexed citations
5.
Lyon, Maureen E., Debra Benator, Rachel K. Scott, et al.. (2018). The Efficacy of FAmily CEntered (FACE) Advance Care Planning on Congruence in End-of-Life Treatment Preferences Between Adults Living with HIV and their Surrogates Over Time. Journal of Pain and Symptom Management. 56(6). e79–e80.
6.
Hall, Karen E., et al.. (2017). HIV Nurse Navigation: Charting the Course to Improve Engagement in Care and HIV Virologic Suppression. Journal of the International Association of Providers of AIDS Care (JIAPAC). 16(6). 603–607. 6 indexed citations
7.
Badal‐Faesen, Sharlaa, Cynthia Firnhaber, Michelle A. Kendall, et al.. (2017). Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis. Journal of Clinical Medicine. 6(8). 78–78. 8 indexed citations
8.
Sterling, Timothy R., Nigel Scott, José M. Miró, et al.. (2016). Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons. AIDS. 30(10). 1607–1615. 103 indexed citations
9.
Tuck, Matthew, et al.. (2016). Anaplastic large cell lymphoma masquerading as osteomyelitis of the shoulder: an uncommon presentation. BMJ Case Reports. 2016. bcr2016217317–bcr2016217317. 11 indexed citations
10.
Luetkemeyer, Anne F., Cynthia Firnhaber, Michelle A. Kendall, et al.. (2016). Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clinical Infectious Diseases. 62(9). 1081–1088. 58 indexed citations
11.
Matthews, Lynn T., David E. Kleiner, Cheryl Chairez, et al.. (2015). Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection. AIDS Research and Human Retroviruses. 31(10). 961–966. 16 indexed citations
12.
Hoffman, Heather J., et al.. (2013). Is Frequent CD4 + T-Lymphocyte Count Monitoring Necessary for Persons With Counts ≥300 Cells/µL and HIV-1 Suppression?: Figure 1.. Clinical Infectious Diseases. 56(9). 1340–1343. 66 indexed citations
13.
Weiner, Marc, Debra Benator, W. J. Burman, et al.. (2005). Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis. Clinical Infectious Diseases. 40(10). 1481–1491. 170 indexed citations
14.
Liappis, Angelike P., et al.. (2004). Syphilitic Hepatitis in HIV-Infected Patients: A Report of 7 Cases and Review of the Literature. Clinical Infectious Diseases. 39(10). e100–e105. 86 indexed citations
15.
Weiner, Marc, William J. Burman, Andrew Vernon, et al.. (2003). Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and Rifapentine. American Journal of Respiratory and Critical Care Medicine. 167(10). 1341–1347. 151 indexed citations
16.
Watson, Timothy F., et al.. (2003). Kikuchi Disease Presenting as a Flu-Like Illness with Rash and Lymphadenopathy. The American Journal of the Medical Sciences. 325(1). 34–37. 16 indexed citations
17.
Kumari, Poonam, et al.. (2000). Successful Treatment of Human Immunodeficiency Virus-Related Castleman's Disease with Interferon- . Clinical Infectious Diseases. 31(2). 602–604. 31 indexed citations
18.
Benator, Debra, et al.. (1997). Mycobacterium szulgai Infection of the Lung: Case Report and Review of an Unusual Pathogen. The American Journal of the Medical Sciences. 313(6). 346–351. 31 indexed citations
19.
Gordin, Fred M., Eileen T. Nelson, John P. Matts, et al.. (1996). The Impact of Human Immunodeficiency Virus Infection on Drug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 154(5). 1478–1483. 57 indexed citations
20.
French, Audrey L., et al.. (1995). Cholecystectomy in Patients with AIDS: Clinicopathologic Correlations in 107 Cases. Clinical Infectious Diseases. 21(4). 852–858. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandrasekaran Padmapriyadarsini Breakdown of academic impact, for papers by Peter Phillips Breakdown of academic impact, for papers by Lee B. Reichman Breakdown of academic impact, for papers by Alice K. Pau Breakdown of academic impact, for papers by Işık Somuncu Johansen Breakdown of academic impact, for papers by Weerawat Manosuthi Breakdown of academic impact, for papers by Gregory P. Bisson Breakdown of academic impact, for papers by George PrayGod Breakdown of academic impact, for papers by Anne F. Luetkemeyer Breakdown of academic impact, for papers by Sasisopin Kiertiburanakul
Rankless by CCL
2026